74 related articles for article (PubMed ID: 17659494)
1. [Model's short life and murine resistance, another ''no'' revolution].
Cornacchia F
G Ital Nefrol; 2007; 24(4):282. PubMed ID: 17659494
[No Abstract] [Full Text] [Related]
2. Diabetic endothelial nitric oxide synthase knockout mice develop advanced diabetic nephropathy.
Nakagawa T; Sato W; Glushakova O; Heinig M; Clarke T; Campbell-Thompson M; Yuzawa Y; Atkinson MA; Johnson RJ; Croker B
J Am Soc Nephrol; 2007 Feb; 18(2):539-50. PubMed ID: 17202420
[TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial dysfunction: a tug of war in diabetic nephropathy?
Balakumar P; Chakkarwar VA; Krishan P; Singh M
Biomed Pharmacother; 2009 Mar; 63(3):171-9. PubMed ID: 18823739
[TBL] [Abstract][Full Text] [Related]
4. Angiopoietin-1 gene transfer improves impaired wound healing in genetically diabetic mice without increasing VEGF expression.
Bitto A; Minutoli L; Galeano MR; Altavilla D; Polito F; Fiumara T; Calò M; Lo Cascio P; Zentilin L; Giacca M; Squadrito F
Clin Sci (Lond); 2008 Jun; 114(12):707-18. PubMed ID: 18078386
[TBL] [Abstract][Full Text] [Related]
5. A breakthrough in diabetic nephropathy: the role of endothelial dysfunction.
Nakagawa T; Segal M; Croker B; Johnson RJ
Nephrol Dial Transplant; 2007 Oct; 22(10):2775-7. PubMed ID: 17595179
[No Abstract] [Full Text] [Related]
6. Long-term blockade of vascular endothelial growth factor receptor-2 aggravates the diabetic renal dysfunction associated with inactivation of the Akt/eNOS-NO axis.
Kim HW; Lim JH; Kim MY; Chung S; Shin SJ; Chung HW; Choi BS; Kim YS; Chang YS; Park CW
Nephrol Dial Transplant; 2011 Apr; 26(4):1173-88. PubMed ID: 20935017
[TBL] [Abstract][Full Text] [Related]
7. Toward a mouse model of diabetic nephropathy: is endothelial nitric oxide synthase the missing link?
Quaggin SE; Coffman TM
J Am Soc Nephrol; 2007 Feb; 18(2):364-6. PubMed ID: 17259594
[No Abstract] [Full Text] [Related]
8. Augmentation of vascular remodeling by uncoupled endothelial nitric oxide synthase in a mouse model of diabetes mellitus.
Sasaki N; Yamashita T; Takaya T; Shinohara M; Shiraki R; Takeda M; Emoto N; Fukatsu A; Hayashi T; Ikemoto K; Nomura T; Yokoyama M; Hirata K; Kawashima S
Arterioscler Thromb Vasc Biol; 2008 Jun; 28(6):1068-76. PubMed ID: 18403727
[TBL] [Abstract][Full Text] [Related]
9. Ameliorative effect of berberine on endothelial dysfunction in diabetic rats induced by high-fat diet and streptozotocin.
Wang C; Li J; Lv X; Zhang M; Song Y; Chen L; Liu Y
Eur J Pharmacol; 2009 Oct; 620(1-3):131-7. PubMed ID: 19686728
[TBL] [Abstract][Full Text] [Related]
10. Obesity and endothelial function.
Duncan ER; Shah AM; Kearney MT
Circ Res; 2005 Aug; 97(4):e52. PubMed ID: 16109922
[No Abstract] [Full Text] [Related]
11. Central insulin regulates heart rate and arterial blood flow: an endothelial nitric oxide synthase-dependent mechanism altered during diabetes.
Cabou C; Cani PD; Campistron G; Knauf C; Mathieu C; Sartori C; Amar J; Scherrer U; Burcelin R
Diabetes; 2007 Dec; 56(12):2872-7. PubMed ID: 17804761
[TBL] [Abstract][Full Text] [Related]
12. [Diabetic nephropathy: physiopathology and clinical course].
Macía Heras M; Macía Jerez M; Coronel F
Nefrologia; 2001; 21 Suppl 3():24-31. PubMed ID: 11642203
[No Abstract] [Full Text] [Related]
13. The TGF mechanism is not needed for development of glomerular hyperfiltration in diabetes.
Skøtt O
Acta Physiol (Oxf); 2007 Jul; 190(3):177. PubMed ID: 17581132
[No Abstract] [Full Text] [Related]
14. Chronic inhibition of inducible nitric oxide synthase ameliorates cardiovascular abnormalities in streptozotocin diabetic rats.
Nagareddy PR; McNeill JH; MacLeod KM
Eur J Pharmacol; 2009 Jun; 611(1-3):53-9. PubMed ID: 19344709
[TBL] [Abstract][Full Text] [Related]
15. Direct Observation of Enhanced Nitric Oxide in a Murine Model of Diabetic Nephropathy.
Boels MG; van Faassen EE; Avramut MC; van der Vlag J; van den Berg BM; Rabelink TJ
PLoS One; 2017; 12(1):e0170065. PubMed ID: 28103268
[TBL] [Abstract][Full Text] [Related]
16. Diabetic nephropathy is associated with oxidative stress and decreased renal nitric oxide production.
Prabhakar S; Starnes J; Shi S; Lonis B; Tran R
J Am Soc Nephrol; 2007 Nov; 18(11):2945-52. PubMed ID: 17928507
[TBL] [Abstract][Full Text] [Related]
17. Glomerular endothelial NOS (eNOS) expression in type 2 diabetic patients with nephropathy.
Komers R; Anderson S
Nephrol Dial Transplant; 2008 Sep; 23(9):3037; author reply 3037-8. PubMed ID: 18596128
[No Abstract] [Full Text] [Related]
18. Activated protein C protects against diabetic nephropathy by inhibiting endothelial and podocyte apoptosis.
Isermann B; Vinnikov IA; Madhusudhan T; Herzog S; Kashif M; Blautzik J; Corat MA; Zeier M; Blessing E; Oh J; Gerlitz B; Berg DT; Grinnell BW; Chavakis T; Esmon CT; Weiler H; Bierhaus A; Nawroth PP
Nat Med; 2007 Nov; 13(11):1349-58. PubMed ID: 17982464
[TBL] [Abstract][Full Text] [Related]
19. Roles of endothelial oxidases in endothelium-derived hyperpolarizing factor responses in mice.
Takaki A; Morikawa K; Murayama Y; Yamagishi H; Hosoya M; Ohashi J; Shimokawa H
J Cardiovasc Pharmacol; 2008 Dec; 52(6):510-7. PubMed ID: 19034034
[TBL] [Abstract][Full Text] [Related]
20. Molecular mechanism of limbs' postischemic revascularization improved by perindopril in diabetic rats.
Gao L; Yu DM
Chin Med J (Engl); 2008 Nov; 121(21):2129-33. PubMed ID: 19080171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
